MLchartDataset catalogue

Zevalin

Term · Oncology and biomedicine · MLC-T-ONC-009474

A drug used to treat adults with certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Zevalin contains a monoclonal antibody that binds to a protein called CD20, which is found on B cells and some types of lymphoma cells. It also contains the compound tiuxetan, which allows certain radioactive substances to be attached to the monoclonal antibody. This may help kill cancer cells. Zevalin is a type of monoclonal antibody and a type of immunoconjugate. Also called ibritumomab tiuxetan.

Table 1. Record
IdentifierMLC-T-ONC-009474
FieldOncology and biomedicine
Synonymsibritumomab tiuxetan
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-009474",
  "term": "Zevalin",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Zevalin contains a monoclonal antibody that binds to a protein called CD20, which is found on B cells and some types of lymphoma cells. It also contains the compound tiuxetan, which allows certain radioactive substances to be attached to the monoclonal antibody. This may help kill cancer cells. Zevalin is a type of monoclonal antibody and a type of immunoconjugate. Also called ibritumomab tiuxetan.",
  "synonyms": [
    "ibritumomab tiuxetan"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/zevalin/"
}

Record 17,626 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.